Boston Scientific, Medtronic and J&J are moving quickly to secure their place in the fast-growing pulsed field ablation space ...

Abbott has reached two milestones in a pair of trials evaluating the company’s pulsed field ablation (PFA) technology for the ...

Enrollment completed ahead of schedule in the global IDE for Abbott's Volt™ PFA System Global FOCALFLEX trial now underway for Abbott's TactiFlex™ Duo Ablation Catheter, Sensor Enabled™ Advisor™ HD ...

Boston Scientific is resuming its "Avant Guard" study of pulse field ablation (PFA) as a first-line therapy for atrial ...

The Sphere-360 catheter was designed to simplify the ... study designed to evaluate the safety and effectiveness of Abbott's Volt PFA System. Boston Scientific too in January 2024, received ...

Competition in the fast-growing pulsed field ablation (PFA) market has intensified with ... J&J, Boston Scientific and Abbott executives described a changing AFib treatment landscape on their ...

Affera combines mapping technology with a catheter capable of performing ... the electrophysiology market. So far, Abbott has identified the launches of PFA devices by rivals as a factor that ...

We think it’s likely that Boston can translate its fast start with Farapulse into new leadership in AF ablation, especially as Johnson & Johnson and Abbott are lagging behind with their own PFA ...